QIAscreen HPV PCR Test
- UID
- IMP/IVD/2023/000088_8c4e6e23734afe3cf0bbe804263e07db_e77b7f9db0caaa3c5a0876380f30e54b
- Device class
- Class C
- Brand name
- QIAscreen HPV PCR Test
- License holder
- QIAGEN India Pvt. Ltd
- Approving authority
- CDSCO
- Product information
- The QIAscreen HPV PCR Test is an in vitro real-time PCR-based assay for the qualitative detection of human papillomavirus (QIAscreen HPV PCR Test) DNA of the following 15 (QIAscreen HPV PCR Test) high-risk HPV genotypes, i.e 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, and 68. The assay is intended to be used for the screening of women for the risk of cervical (QIAscreen HPV PCR Test)cancer.
QIAscreen HPV PCR Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000088_8c4e6e23734afe3cf0bbe804263e07db_e77b7f9db0caaa3c5a0876380f30e54b. This device is marketed under the brand name QIAscreen HPV PCR Test. The license holder is QIAGEN India Pvt. Ltd, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.